Combined serum and immunohistochemical differentiation between reactive, and malignant mesothelial proliferations

Combined serum and immunohistochemical differentiation between reactive, and malignant mesothelial proliferations

Background: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative chemotherapy remain low. The diagnosis of malignant mesothelioma is frequently difficult, the most common differential diagnosis being reactive pleural conditions and metastatic adenocarcinoma. Several...

Full description

Bibliographic Details
Main Authors: Gehan F. Al mehy, Ghada A. Abd El-Fattah, Mohebat H. Gouda, Rasha M. El-Sawi, Mostafa M. Amer
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-07-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Reactive mesothelial proliferation
Atypical mesothelial proliferation
Mesothelioma
Desmin
Epithelial membrane antigen (EMA)
Serum mesothelin related peptide (SMRP)
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763815300091

Internet

http://www.sciencedirect.com/science/article/pii/S0422763815300091

Similar Items